fangchinoline has been researched along with Liver Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, KS; Jung, YY; Sethi, G; Um, JY | 1 |
| Chan, YT; Feng, Y; Feng, Z; Huang, L; Lan, J; Liu, Y; Lu, Y; Pan, W; Wang, N | 1 |
| Feng, Y; Hao, X; Liang, G; Pan, W; Wang, N; Zhang, M; Zhu, M | 1 |
3 other study(ies) available for fangchinoline and Liver Neoplasms
| Article | Year |
|---|---|
Fangchinoline abrogates growth and survival of hepatocellular carcinoma by negative regulation of c-met/HGF and its associated downstream signaling pathways.
Topics: Animals; Benzylisoquinolines; Carcinoma, Hepatocellular; Disease Models, Animal; Hep G2 Cells; Hepatocyte Growth Factor; Humans; Liver Neoplasms; Mice; Phosphatidylinositol 3-Kinases; Signal Transduction | 2022 |
Thioredoxin-interacting protein-activated intracellular potassium deprivation mediates the anti-tumour effect of a novel histone acetylation inhibitor HL23, a fangchinoline derivative, in human hepatocellular carcinoma.
Topics: Acetylation; Animals; Carcinoma, Hepatocellular; Histone Deacetylases; Histones; Humans; Liver Neoplasms; Mice; Sorafenib; Thioredoxins; Vorinostat | 2023 |
Fangchinoline induces autophagic cell death via p53/sestrin2/AMPK signalling in human hepatocellular carcinoma cells.
Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Autophagy; Benzylisoquinolines; Carcinoma, Hepatocellular; Cell Line, Tumor; Hep G2 Cells; Humans; Liver Neoplasms; Membrane Proteins; Nuclear Proteins; Protein Transport; Proteins; Signal Transduction; TOR Serine-Threonine Kinases; Transcriptional Activation; Tumor Suppressor Protein p53 | 2011 |